Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 10,340
-210 (-1.99%)
May 11, 2026, 2:45 PM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2025, Teva Pharmaceutical Industries had 32,842 total employees, including 31,173 full-time and 1,669 part-time employees. The number of employees decreased by 2,844 or -7.97% compared to the previous year.
Employees
32,842
Change
-2,844
Growth
-7.97%
Revenue / Employee
1.71M ILS
Profits / Employee
154.37K ILS
Market Cap
120.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 32,842 | -2,844 | -7.97% | 31,173 | 1,669 |
| Jun 30, 2025 | 37,000 | 0 | - | 37,000 | 0 |
| Mar 31, 2025 | 37,000 | 528 | 1.45% | 37,000 | 0 |
| Dec 31, 2024 | 35,686 | -786 | -2.16% | 33,892 | 1,794 |
| Sep 30, 2024 | 37,000 | 528 | 1.45% | 37,000 | 0 |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% | 35,001 | 1,471 |
| Dec 31, 2022 | 35,125 | -854 | -2.37% | 34,004 | 1,121 |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% | 34,713 | 1,266 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kamada | 462 |
| Rekah Pharmaceutical Industry | 390 |
| InterCure | 320 |
| Together Pharma | 210 |
| Seach Medical Group | 162 |
| Tikun Olam-Cannbit Pharmaceuticals | 19 |
Teva Pharmaceutical Industries News
- 3 days ago - Insider Sell: Amir Weiss Sells Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 4 days ago - Teva price target raised to $40 from $38 at Barclays - TheFly
- 4 days ago - Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
- 5 days ago - Insider Sell Alert: Mark Sabag Sells 144,180 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 6 days ago - Teva to Present at the BofA Securities Health Care Conference - GlobeNewsWire
- 10 days ago - TEVA Maintained by JP Morgan -- Price Target Raised to $40.00 - GuruFocus
- 10 days ago - TEVA Maintained by UBS -- Price Target Raised to $42.00 - GuruFocus
- 10 days ago - TEVA Reiterated by Piper Sandler -- Price Target Raised to $42.00 - GuruFocus